UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | X | Y
Number of items: 183.

A

Aitchison, KA; Baxter, GF; Yellon, DM; Opie, LH; (1998) Delta opioid receptors mediate ischaemic preconditioning in the isolated rat heart. In: (pp. 603-).

Aitchison, KA; Baxter, GF; Yellon, DM; Opie, LH; (1998) Involvement of delta opioid receptor subtypes in ischaemic preconditioning against infarction in the rat isolated heart. In: BRIT J PHARMACOL. (pp. ? - ?). STOCKTON PRESS

Al Saffar, B; Hu, M; Richards, M; Winkler, A; Agapito, C; Brooks, DJ; Ray, C; (1998) Do immigrant Afro-Caribbean and Indian subjects suffer from an atypical levodopa hyporesponsive parkinsonism. In: (pp. p. 385).

Archer, N; Burch, M; (1998) Paediatric Cardiology: An Introduction. [Book]. Chapman and Hall: London UK.

B

BURCH, M; (1998) Echocardiography in Pediatric Heart Disease. Archives of Disease in Childhood , 78 (3) p. 288. 10.1136/adc.78.3.e288.

Baxter, GF; Mocanu, MM; Yellon, DM; (1998) Infarct-limiting action of transforming growth factor beta 1 in isolated rat heart is abolished by the p38 MAPK inhibitor SB203580. CIRCULATION , 98 (17) 71 - 72.

Baxter, GF; Mocanu, MM; Yellon, DM; (1998) Infarct-limiting action of transforming growth factor beta-1 in isolated rat heart is abolished by the p38 MAPK inhibitor SB203580. In: (pp. I 71-I 72).

Baxter, GF; Muller, CA; Latouf, SE; McCarthy, J; Opie, LH; Yellon, DM; (1998) Brief coronary artery occlusions by intracoronary balloon inflation induce delayed preconditioning against infarction in pig myocardium. In: (pp. I 619-I 620).

Baxter, GF; Muller, CA; Latouf, SE; McCarthy, J; Opie, LH; Yellon, DM; (1998) Brief coronary artery occlusions by intracoronary balloon inflation induce delayed preconditioning against infarction in pig myocardium. CIRCULATION , 98 (17) 619 - 620.

Baxter, GF; Yellon, DM; (1998) Delayed Preconditioning and Adaptive Cardioprotection. [Book]. Kluwer Academic Publishers: Dordrecht.

Baxter, GF; Yellon, DM; (1998) Increased myocardial tolerance to ischaemia 24 h after adenosine A(1) receptor stimulation: Evidence for a role of the ATP-sensitive K+ channel. In: BRIT J PHARMACOL. (pp. ? - ?). STOCKTON PRESS

Baxter, GF; Yellon, DM; (1998) KATP channel blockade abolishes delayed anti-ischaemic actions of transient adenosine A1 receptor activation. In: (pp. 32-).

Baxter, GF; Yellon, DM; (1998) The delayed anti-ischaemic action of transient adenosine A1 receptor activation is abolished by blockade of the ATP-sensitive K<sup>+</sup> channel in rabbit myocardium. In: (pp. P10-).

Baxter, GF; Yellon, DM; (1998) Delayed preconditioning against lethal ischaemic injury. In: Baxter, GF and Yellon, DM, (eds.) Delayed Preconditioning and Adaptive Cardioprotection. (pp. 1-28). Kluwer Academic Publishers: Dordrecht.

Bell, RM; Yellon, DM; (1998) Molecular mechanisms of preconditioning: Therapeutic implications. Revista Portuguesa de Cardiologia , 17 (SUPPL. 2) pp. 49-61.

Bell, RM; Yellon, DM; (1998) Molecular mechanisms of preconditioning: therapeutic implications. Rev Port Cardiol , 17 Sup II49-II61.

Bell, SP; Sack, MN; Patel, A; Opie, LH; Yellon, DM; (1998) Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. In: (pp. I 486-).

Bell, SP; Sack, MN; Patel, A; Opie, LH; Yellon, DM; (1998) Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. CIRCULATION , 98 (17) 486 - 486.

Bell, SP; Yellon, DM; (1998) Identification of a potential signalling pathway for ischaemic preconditioning in human heart muscle. In: (pp. P29-).

Blaikley, JF; Sutton, PM; Walter, MF; Sumeray, MS; Woolfson, R; Unwin, R; (1998) Neutral endopeptidase enzymuria following cardiac bypass surgery. In: (pp. pp. 82-83).

Boyd, Y; Blair, HJ; Cunliffe, P; Denny, P; Gormally, E; Herman, GE; (1998) Encyclopedia of the mouse genome VII. Mouse chromosome X. Mammalian genome : official journal of the International Mammalian Genome Society , 8 Spec

Boyd, Y; Blair, HJ; Cunliffe, P; Denny, P; Gormally, E; Herman, GE; (1998) Mouse chromosome X. Mammalian Genome , 8 (SPEC. IS) 10.1007/s003359900665.

Burnett, S; Hurwitz, B; Davey, C; Ray, J; Chaturvedi, N; Salzmann, J; Yudkin, JS; (1998) The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of north London: a quality of care study. DIABETIC MEDICINE , 15 (11) S38-S43. 10.1002/(SICI)1096-9136(1998110)15:3+<S38::AID-DIA729>3.3.CO;2-K.

Byrne, CD; Wareham, NJ; Martensz, ND; Humphries, SE; Metcalfe, JC; Grainger, DJ; (1998) Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-beta levels. ATHEROSCLEROSIS , 140 (1) pp. 45-53.

C

Cai, Q; Baxter, GF; Yellon, DM; (1998) Protein phosphatase inhibitors reduce infarct size in the isolated rat heart. In:

Cai, Q; Baxter, GF; Yellon, DM; (1998) Reduction in infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibition. Cardiovascular Drugs and Therapy , 12 pp. 449-451.

Carroll, R; Yellon, DM; (1998) Heat stress proteins and their relationship to myocardial protection. In: Latchman, DS, (ed.) Stress Proteins. (pp. 265-280). Springer 136

Casiglia, E; Tikhonoff, V; Pizziol, A; Onesto, C; Ginocchio, G; Mazza, A; Pessina, AC; (1998) Should digoxin be proscribed in elderly subjects in sinus rhythm free from heart failure? A population-based study. Jpn Heart J , 39 (5) pp. 639-651. Gold open access

Chambers, JC; Lambiase, P; Thomas, N; Jean-Marie, J; Kooner, JS; (1998) Endothelium dependent dilatation is impaired in first degree relatives of UK Indian Asian patients with premature coronary heart disease - evidence for a genetic influence. In: CIRCULATION. (pp. 847 - 847). LIPPINCOTT WILLIAMS & WILKINS

Chaturvedi, N; Fuller, JH; (1998) Angiotensin II, VEGF, and diabetic retinopathy - Reply. LANCET , 351 (9105) p. 837. 10.1016/S0140-6736(05)78973-X.

Chaturvedi, N; Sjolie, AK; Stephenson, JM; Abrahamian, H; Keipes, M; Castellarin, A; Rogulja-Pepeonik, Z; ... EUCLID Study Group, ; + view all (1998) Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The Lancet , 351 (9095) pp. 28-31. 10.1016/S0140-6736(97)06209-0.

Chow, LT; Cook, AC; Ho, SY; Leung, MP; Anderson, RH; (1998) Isolated congenitally complete heart block attributable to combined nodoventricular and intraventricular discontinuity. Hum Pathol , 29 (7) pp. 729-736.

Clapp, LH; Tinker, A; (1998) Potassium channels in the vasculature. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION , 7 (1) pp. 91-98.

Cohen, A; Bregman, B; Agabiti Rosei, E; Williams, B; Dubourg, O; Clairefond, P; Brudi, P; ... Guéret, P; + view all (1998) Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. J Hum Hypertens , 12 (7) pp. 479-483.

Cooper, M; Yellon, DM; Marber, MS; (1998) A model of hypoxic preconditioning in adult rabbit cardiac myocytes in culture. In: (pp. P33-).

Curran, JM; Evans, A; Arveiler, D; Luc, G; Ruidavets, JB; Humphries, SE; Green, FR; (1998) The alpha fibrinogen T/A312 polymorphism in the ECTIM study. THROMB HAEMOSTASIS , 79 (5) 1057 - 1058.

D

Dana, A; Baxter, GF; Walker, JM; Yellon, DM; (1998) Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state [see comments]. J AM COLL CARDIOL , 31 (5) pp. 1142-1149.

Dana, A; Baxter, GF; Walker, JM; Yellon, DM; (1998) Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains the rabbit myocardium in a preconditioned state. Journal of the American College of Cardiology , 31 pp. 1142-1149.

Dana, A; Sumeray, MS; Yellon, DM; (1998) Ischaemic preconditioning: a clinical perspective. HOSP MED , 59 (3) 216 - 220.

Dana, A; Yamashita, N; Baxter, GF; Yellon, DM; (1998) Involvement of protein kinases and manganese-superoxide dismutase in adenosine induced delayed preconditioning. In: (pp. 292-).

Dana, A; Yamashita, N; Walker, JM; Baxter, GF; Yellon, DM; (1998) Delayed adenosine induced pharmacological preconditioning: Involvement of protein kinases and Mn-superoxide dismutase. Heart , 79 (SUPPL. 1)

Dana, A; Yamashita, N; Walker, JM; Baxter, GF; Yellon, DM; (1998) Delayed adenosine induced pharmacological preconditioning: involvement of protein kinases and Mn-superoxide dismutase. In: (pp. P9-).

Dana, A; Yellon, DM; (1998) Angina: who needs it? Cardioprotection in the preconditioning era. Cardiovasc Drugs Ther , 12 (6) pp. 515-528.

Dana, A; Yellon, DM; (1998) Cardioprotection by pre-infarct angina: is it ischaemic preconditioning? EUR HEART J , 19 (3) 367 - 369.

Dana, A; Yellon, DM; (1998) Cardioprotection by pre-infarct angina: is it ischaemic preconditioning? [editorial]. EUR HEART J , 19 (3) pp. 367-369.

Dana, A; Yellon, DM; (1998) Novel cardioprotective agents in acute coronary syndromes: a role for nicorandil? British Journal of Cardiology , 5 (4) pp. 186-187.

Dana, A; Yellon, DM; Baxter, GF; (1998) Adenosine and adaptive cardioprotection. In: Baxter, GF and Yellon, DM, (eds.) Delayed Preconditioning and Adaptive Cardioprotection. (pp. 189-207). Kluwer Academic Publishers

De, O; Haddad, L; Kwiterovich, PO; Jr, H; S E, D; I, N; (1998) Applicability of LDLR flanking microsatellite polymorphisms for prenatal diagnosis of homozygous state for familial hypercholesterolemia. CLIN GENET , 53 (5) pp. 375-378.

De Stefano, V; Dekou, V; Nicaud, V; Chasse, JF; London, J; Stansbie, D; Humphries, SE; (1998) Linkage disequilibrium at the cystathionine beta synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine. The Ears II Group. European Atherosclerosis Research Study. Ann Hum Genet , 62 (Pt 6) pp. 481-490. 10.1046/j.1469-1809.1998.6260481.x.

Deanfield, JE; (1998) Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: The Circadian Anti-ischemia Program in Europe (CAPE) II trial - Clinical rationale and methodology. CARDIOVASCULAR DRUGS AND THERAPY , 12 pp. 239-242. 10.1023/A:1007769808941.

Deanfield, JE; (1998) At what age is primary prevention important. In:

Dewberry, RM; Camp, NJ; Gunn, J; Burton, AJ; Carter, ND; Jeffery, S; Syrris, P; ... Francis, SE; + view all (1998) Interleukin-1 (IL-1) gene polymorphisms: Risk of coronary arterial disease. Heart , 79 (SUPPL. 1)

Doggen, CJM; Kunz, G; Rosendaal, FR; Lane, DA; Vos, HL; Stubbs, PJ; Cats, VM; (1998) A mutation in the thrombomodulin gene, (127)G to a coding for Ala25Thr, and the risk of myocardial infarction in men. THROMB HAEMOSTASIS , 80 (5) 743 - 748.

Downey, JM; Yellon, DM; (1998) The biology of preconditioning. In: Vatner, SF and Heyndrickx, GR and Wijns, W, (eds.) Stunning, hibernation and preconditioning: Clinical pathophysiology of ischemia. (pp. 105-119). Lippincott-Raven Publishers: Philadelphia.

E

Elliott, P; McKenna, WJ; (1998) Identification and management of high risk patients with hypertrophic cardiomyopathy. In: Camerini, F and Gavazzi, A and De Maria, R, (eds.) Advances in Cardiomyopathies. (pp. 42-50). Springer-Verlag Italia: Milan.

Elliott, P; McKenna, WJ; (1998) Hypertrophic cardiomyopathy. In: Topol, EJ and Califf, RM and Isner, JM and Prystowsky, EN and Serruys, PW and Swain, JL and Thomas, JD and Thompson, PD and Young, JB, (eds.) Textbook of Cardiovascular Medicine. (pp. 745-768). Lippincott-Raven Publishers: Philadelphia.

Elliott, P; Poloniecki, J; Sharma, S; Varnarva, A; McKenna, WJ; (1998) Relation of left ventricular hypertrophy to survival in hypertrophic cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , 31 (2) 26A-26A. 10.1016/S0735-1097(97)83828-4.

Elliott, P; Sharma, S; Prasad, K; Varnarva, A; McKenna, W; (1998) Outcome of patients with hypertrophic cardiomyopathy that survive cardiac arrest. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , 31 (2) 245A-245A. 10.1016/S0735-1097(97)84772-9.

Elliott, PM; Brecker, SJ; McKenna, WJ; (1998) Diastolic dysfunction in hypertrophic cardiomyopathy (Editorial). European Heart Journal , 19 pp. 1125-1127.

Elliott, PM; Brecker, SJ; McKenna, WJ; (1998) Diastolic function in hypertrophic cardiomyopathy. European Heart Journal , 19 pp. 1125-1127.

Elliott, PM; McKenna, WJ; (1998) Risk stratification in patients with hypertrophic cardiomyopathy. In: Vardas, PE, (ed.) UNSPECIFIED (pp. 83-88). SPRINGER

Elliott, PM; Poloniecki, J; Sharma, S; Dickie, S; McKenna, WJ; (1998) Amiodarone therapy and sudden death in patients with hypertrophic cardiomyopathy. Heart , 79 (SUPPL. 1)

Elliott, PM; Poloniecki, J; Sharma, S; Dickie, S; McKenna, WJ; (1998) Non-invasive risk stratification in hypertrophic cardiomyopathy. Heart , 79 (SUPPL. 1)

Elliott, PM; Sharma, S; McKenna, WJ; (1998) Hypertrophic cardiomyopathy. In: Yusuf, S and Cairns, JA and Camm, AJ and Fallen, EL and Gersh, BJ, (eds.) Evidence Based Cardiology. (pp. 722-743). BMJ Books

Englund, A; Hnatkova, K; Kulakowski, P; Elliot, PM; McKenna, WJ; Malik, M; (1998) Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy. EUROPEAN HEART JOURNAL , 19 (9) pp. 1383-1390. 10.1053/euhj.1998.1082.

F

Fairbanks, VF; Brandhagen, DJ; Thibodeau, S; Snow, K; Wollan, PC; (1998) H63D is an haemochromatosis associated allele. GUT , 43 (3) p. 441. 10.1136/gut.43.3.441.

Fairbanks, VF; Brandhagen, DJ; Thibodeau, SN; Snow, K; Wollan, PC; (1998) H63D is an haemochromatosis associated allele. Gut , 43 (3) pp. 441-442.

Finer, N; Booth, DA; (1998) Obesity (ap970151). Appetite , 30 (1) p. 96.

Fishman, D; Faulds, G; Jeffery, R; Mohamed, A; Yudkin, JS; Humphries, S; Woo, P; (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J CLIN INVEST , 102 (7) pp. 1369-1376.

Fredericks, S; Syrris, P; Kaski, JC; Jeffery, S; Holt, DW; Carter, ND; Xing, LW; (1998) 'Comments on circulating transforming growth factor β1 and coronary artery disease' [2] (multiple letters). Cardiovascular Research , 37 (3) pp. 829-830.

G

Garcha, RS; Sever, PS; Hughes, AD; (1998) Action of losartan metabolite E-3174, tyrosine kinase inhibition and calcium channel blockade on angiotensin-II (AII) responses in human resistance arteries. FASEB Journal , 12 (5)

Garcha, RS; Sever, PS; Hughes, AD; (1998) Angiotensin II contracts human resistance arteries via tyrosine kinase activation and calcium channel opening. JOURNAL OF HYPERTENSION , 16 S3-S3.

Garcha, RS; Sever, PS; Hughes, AD; (1998) Role of Ca2+ channels, MAP/ERK kinase (MEK) in angiotensin II-induced contraction in human isolated resistance arteries. JOURNAL OF VASCULAR RESEARCH , 35 p. 18.

Gheorghiade, M; Cody, RJ; Francis, GS; McKenna, WJ; Young, JB; Bonow, MO; (1998) Current medical therapy for advanced heart failure. AMERICAN HEART JOURNAL , 135 (6) S231-S248. 10.1016/S0002-8703(98)70253-4.

Gilbert, HL; Acharya, J; Pearson, TC; (1998) Implications for the use of X-chromosome inactivation patterns and their relevance to the myeloproliferative disorders. EUR J HAEMATOL , 61 (4) 282 - 283.

Gilbert, HL; Flora, RS; Todd, R; Sawyer, BM; Acharya, J; Cotter, FE; Pearson, T; (1998) Identification of novel genetic rearrangements associated with the myeloproliferative disorders. BRIT J HAEMATOL , 102 (1) 308 - 308.

Goldman, JH; McKenna, WJ; (1998) The epidemiology of heart failure secondary to coronary artery disease. CORONARY ARTERY DISEASE , 9 (10) pp. 625-628. 10.1097/00019501-199809100-00002.

Gordon, HM; Wallace, DF; Walker, AP; Dooley, JS; Morgan, MY; (1998) The role of HFE mutation in determining predisposition to alcohol-related cirrhosis in a Celtic population. Presented at: UNSPECIFIED.

Gorog, DA; Rakhit, R; Parums, D; Laffan, M; Davies, GJ; (1998) Raised factor VIII is associated with coronary thrombotic events. Heart , 80 (4) pp. 415-417.

Gudnason, V; Stansbie, D; Scott, J; Bowron, A; Nicaud, V; Humphries, S; (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. ATHEROSCLEROSIS , 136 (2) pp. 347-354.

H

Hanna, M; Davis, MB; Sweeney, MG; Nousadeghi, M; Ellis, CJ; Elliott, PM; Wood, NW; (1998) Generalised Chorea in Two Patients Harbouring the Friedreich’s Ataxia Gene Trinucleotide Expansion. Movement Disorders , 13 pp. 339-340.

Hardy, RJ; Wadsworth, MEJ; Kuh, D; (1998) Association between childhood obesity and social class and adult obesity across the life course in a British national cohort. In: (pp. p. 693).

Harrington, LS; Lal, H; Yellon, DM; Woodward, B; Sack, MN; (1998) Glycolytic enzyme gene expression during the development of hypoxia-induced cardiac hypertrophy. CIRCULATION , 98 (17) 539 - 539.

Harrington, LS; Yellon, DM; Woodward, B; Sack, MN; (1998) Glycolytic enzyme gene expression during the development of hypoxia-induced cardiac hypertrophy. In: (pp. I 539-).

Heads, RJ; Baxter, GF; Latchman, DS; Marber, MS; Yellon, DM; (1998) HSP and cytoskeletal protein expression and localisation during delayed preconditioning in the rabbit heart. In: (pp. 69-).

Hodson, EA; Ashley, CC; Hughes, AD; Lymn, JS; (1998) Regulation of phospholipase C delta 1 activity by GTP-binding proteins: rhoA as an inhibitory modulator. In: (pp. S128-).

Home, PD; Lauritzen, T; Ryden, L; Chaturvedi, N; Viberti, G; (1998) Round Table Meeting. 34th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 8 September 1998: Optimising the use of ACE inhibitors in diabetes care. Practical Diabetes International , 15 (8 SUPPL.) 10.1002/pdi.1960150813.

Hughes, AD; Clunn, GF; Lymn, JS; Sampson, LJ; Patel, MK; Sever, PS; (1998) Differentiation state affects the ability of Ca2+ channel antagonists to inhibit migration in human vascular smooth muscle cells. JOURNAL OF HYPERTENSION , 16 S16-S16.

Hughes, AD; Garcha, RS; Sever, PS; (1998) Application of a two state model to the action of AT(1) antagonists in human resistance arteries. JOURNAL OF VASCULAR RESEARCH , 35 p. 20.

Hughes, AD; Wijetunge, S; (1998) Role of tyrosine phosphorylation in excitation-contraction coupling in vascular smooth muscle. ACTA PHYSIOLOGICA SCANDINAVICA , 164 (4) pp. 457-469.

Humphries, SE; Fisher, RM; Miller, G; Ye, S; Henney, A; Talmud, PJ; (1998) Predisposing genes, high-risk environments and coronary artery disease: LPL and MMP-3 as examples. In: Jacotot, B and Mathe, D and Fruchart, JC, (eds.) ATHEROSCLEROSIS XI. (pp. 1055 - 1059). ELSEVIER SCIENCE BV

Humphries, SE; Luong, LA; Talmud, PJ; Frick, MH; Kesaniemi, YA; Pasternack, A; Taskinen, MR; (1998) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. ATHEROSCLEROSIS , 139 (1) 49 - 56.

Humphries, SE; Luong, LA; Talmud, PJ; Frick, MH; Kesäniemi, YA; Pasternack, A; Taskinen, MR; (1998) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis , 139 (1) pp. 49-56.

Humphries, SE; Nicaud, V; Margalef, J; Tiret, L; Talmud, PJ; EARS, ; (1998) Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides - The European Atherosclerosis Research Study (EARS). ARTERIOSCL THROM VAS , 18 (4) 526 - 534.

I

Imagawa, J; Baxter, GF; Yellon, DM; (1998) Delayed preconditioning against infarction may involve inducible nitric oxide synthase. In: (pp. P10-).

Imagawa, J; Baxter, GF; Yellon, DM; (1998) Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J CARDIOVASC PHARM , 31 (1) 74 - 79.

Imagawa, J; Baxter, GF; Yellon, DM; (1998) Role of inducible nitric oxide synthase in delayed ischaemic preconditioning. In: (pp. 74-).

J

Jeppsson, A; Tazelaar, HD; Miller, VM; McGregor, CG; (1998) Distribution of endothelin-1 in transplanted human lungs. Transplantation , 66 (6) pp. 806-809.

Joyeux, M; Godin-Ribuot, D; Patel, A; Demenge, P; Yellon, DM; Ribuot, C; (1998) Infarct size-reducing effect of heat stress and alpha(1) adrenoceptors in rats. BRIT J PHARMACOL , 125 (4) 645 - 650.

Joyeux, M; Godin-Ribuot, D; Yellon, DM; Demenge, P; Ribuot, C; (1998) Implications of p38 map kinase and K<sub>ATP</sub> channels in the heart stress-induced myocardial protection.<sub> </sub>. In: (pp. 586-).

Joyeux, M; Lagneux, C; Bricca, G; Yellon, DM; Demenge, P; Ribuot, C; (1998) Heat stress-induced resistance to myocardial infarction in the isolated heart from transgenic [(mREN-2)27] hypertensive rats. CARDIOVASC RES , 40 (1) 124 - 130.

K

Kooyman, DL; Byrne, GW; Logan, JS; (1998) Glycosyl phosphatidylinositol anchor. Exp Nephrol , 6 (2) pp. 148-151.

Kuh, D; Hardy, RJ; Frohlich, KL; Yusuf, E; (1998) Use of hormone therapy among midlife baby boomers. In: (pp. p. 589).

Kuh, D; Richards, M; Hardy, R; MEJ, W; (1998) A life course study shows that cognitive and reproductive function may be influenced by a common early factor. In:

L

Latchman, DS; Budhram-Mahadeo, V; Parker, M; (1998) The POU domain factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an ERE. Molecular and Cellular Biology , 18 pp. 1029-1041.

Leckie, BJ; Lacy, P; Lidder, S; (1998) Expression of renin and renin binding protein in kidneys of rats with experimental renal hypertension. JOURNAL OF HYPERTENSION , 16 S115-S115.

Lee, WK; Haddad, L; Macleod, MJ; Dorrance, AM; Wilson, DJ; Gaffney, D; Dominiczak, MH; ... Dominiczak, AF; + view all (1998) Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland. Journal of Medical Genetics , 35 (7) pp. 573-578.

Leyva, F; Lambiase, P; Rakhit, R; Wingrove, CS; Stevenson, JC; Gibbs, JS; (1998) Hyperuricemia in pulmonary hypertension and thromboembolic disease. In: CIRCULATION. (pp. 272 - 272). LIPPINCOTT WILLIAMS & WILKINS

Lymn, JS; Clunn, GF; Patel, MK; Rao, SJ; O'Neill, C; Thompson, NT; Hughes, AD; (1998) Phosphatidylinositol 9 kinase activity: A possible target for intervention in vascular disease. In: (pp. p. 806). LIPPINCOTT WILLIAMS & WILKINS

M

Mahon, N; McKenna, WJ; (1998) Calcium channel blockers in cardiac failure. PROGRESS IN CARDIOVASCULAR DISEASES , 41 (3) pp. 191-206. 10.1016/S0033-0620(98)80055-8.

Malik, N; Hagger, R; Syrris, P; Carter, N; Murday, V; Kumar, D; (1998) Are there c-kit gene mutations in chronic idiopathic constipation? GASTROENTEROLOGY , 114 (4) A797 - A797.

Maron, BJ; Nishimura, RA; McKenna, WJ; Rakowski, H; Josephson, ME; Kieval, RS; (1998) Assessment of dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY). CIRCULATION , 98 (17) p. 506.

Mattu, RK; Needham, EWA; Richter, D; Soccio, M; Elliott, PM; McKenna, WJ; (1998) The atrial natriuretic peptide gene as a disease modifier in hypertrophic cardiomyopathy. European Heart Journal , 19 606-.

Mattu, RK; Needham, EWA; Richter, D; Soccio, M; Elliott, PM; McKenna, WJ; (1998) The atrial natriuretic peptide gene as a disease modifier in hypertrophic cardiomyopathy. Heart , 79 (SUPPL. 1)

McKenna, WJ; Coccolo, F; Elliott, PM; (1998) Genes and disease expression in hypertrophic cardiomyopathy. LANCET , 352 (9135) pp. 1162-1163. 10.1016/S0140-6736(98)00033-6.

McKenna, WJ; Coccolo, F; Elliott, PM; (1998) Genes and disease expression in hypertrophic cardiomyopathy. Lancet , 352 pp. 1162-1163.

McKenna, WJ; Elliott, PE; (1998) Diagnostic criteria in hypertrophic cardiomyopathy - another paradigm shift (Editorial). European Heart Journal (19) pp. 539-540.

McKenna, WJ; Elliott, PM; (1998) Diagnostic criteria in hypertrophic cardiomyopathy - another paradigm shift. EUROPEAN HEART JOURNAL , 19 (4) pp. 539-540.

McKenna, WJ; Elliott, PM; (1998) Hypertrophic cardiomyopathy. Evidence-based Cardiovascular Medicine , 2 (4) pp. 89-91. 10.1016/S1361-2611(98)80032-8.

McKenna, WJ; Elliott, PM; (1998) Hypertrophic cardiomyopathy. Evidence-based Cardiovascular Medicine , 2 pp. 889-891.

Merryweather-Clarke, AT; Shearman, JD; Robson, KJH; Pointon, JJ; Liu, YT; Bomford, A; Dooley, J; ... Worwood, M; + view all (1998) Hemochromatosis-related mutation detection. BLOOD , 91 (7) pp. 2620-2621.

Mocanu, MM; Baxter, GF; Yellon, DM; (1998) Anti-ischaemic action of transforming growth factor beta-1 in the rat isolated heart is abolished by the p38 MAPK inhibitor SB203580. In: BRIT J PHARMACOL. (pp. ? - ?). STOCKTON PRESS

Mocanu, MM; Baxter, GF; Yellon, DM; (1998) Transforming growth factor á1protects the ischaemic and reperfused myocardium through p38 MAP kinase signalling pathway. In: (pp. 588-).

Monserrat, L; Elliott, P; Prasad, K; Penas-Lado, M; Castro-Beiras, A; McKenna, W; (1998) Non-sustained ventricular tachycardia and sudden death in hypertrophic cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , 31 (2) 26A-26A. 10.1016/S0735-1097(97)83827-2.

Mullen, MJ; Deanfield, JE; (1998) Flow-mediated dilation and cardiovascular risk factors. In:

Muller, CA; Baxter, GF; Latouf, SE; McCarthy, J; Opie, LH; Yellon, DM; (1998) Delayed preconditioning against infarction in pig heart after PTCA balloon inflations. In: (pp. 286-).

Murda'h, MA; Yi, G; Elliott, P; McKenna, WJ; (1998) New noninvasive electrocardiographic markers of sudden death risk in hypertrophic cardiomyopathy. Giornale Italiano di Cardiologia , 28 pp. 54-56.

N

Nimura, H; Carthon, BC; Maron, BJ; McKenna, WJ; Casey, SA; O'Donoghue, A; Seidman, JG; (1998) Cardiac myosin binding protein C mutations: A molecular basis for elderly-onset "sporadic" hypertrophic cardiomyopathy. CIRCULATION , 98 (17) p. 245.

Nissen, H; Day, LB; Horder, M; Humphries, SE; Day, IN; (1998) Denaturing gradient gel electrophoretic analysis of codons 3456-3553 of the apolipoprotein-B gene in 106 type 11a hyperlipoproteinaemic individuals. ANN CLIN BIOCHEM , 35 (Pt 1) pp. 137-139.

O

O'Dell, SD; Bolla, MK; Miller, GJ; Cooper, JA; Humphries, SE; Day, INM; (1998) W64R mutation in beta-3-adrenergic receptor gene and weight in a large population sample. INT J OBESITY , 22 (4) 377 - 379.

O'Dell, SD; Wilson, DJ; Durrington, PN; Humphries, SE; Day, INM; (1998) CpG-PCR combined with sample pooling and mutant enrichment for CpG mutation screening in population studies. CLIN CHEM , 44 (1) 183 - 185.

P

Pell, TJ; Baxter, GF; Yellon, DM; Drew, GM; (1998) Adenosine receptors and KATP channels are involved in renal preconditioning of the myocardium. In: (pp. p. 65).

Pell, TJ; Baxter, GF; Yellon, DM; Drew, GM; (1998) Renal preconditioning of the myocardium involves KATP channels and adenosine receptors. In: (pp. P9-).

Penno, G; Chaturvedi, N; Talmud, PJ; Cotroneo, P; Manto, A; Nannipieri, M; Luong, LA; (1998) Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes , 47 (9) pp. 1507-1511.

Prasad, K; Baig, MK; Fredericks, S; Holt, DW; Grace, AA; McKenna, WJ; (1998) Potential predictive value of B-type natriuretic peptide in disease progression in dilated cardiomyopathy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , 31 (2) 502A-502A. 10.1016/S0735-1097(97)88186-7.

Prasad, K; Sharma, S; Whyte, G; George, K; Gates, P; Fredericks, S; Holt, DW; (1998) Are serum creatine kinase isoforms and troponin-T useful markers of altered cardiac function after strenuous exercise? CIRCULATION , 98 (17) pp. 431-432.

R

Richards, M; Kuh, D; Hardy, RJ; Wadsworth, MEJ; (1998) Cognitive performance across the lifespan and menopause transition in a national UK birth cohort. In: (pp. p. 337).

Richards, M; Stern, Y; Hardy, RJ; Wadsworth, MEJ; (1998) Childhoot IQ, education and midlife cognitive function in a national UK birth cohort. In: (pp. p. 213).

S

Sharland, GK; Cook, AC; (1998) Pulmonary atresia with intact inter ventricular septum. In: Redington, AN and Brawn, WJ and Deanfield, JD and Anderson, RH, (eds.) The right heart in congenital heart disease. Greenwich Medical Media: London.

Sharma, P; Hingorani, A; Jia, H; Ashby, M; Hopper, R; Clayton, D; Brown, MJ; (1998) Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. HYPERTENSION , 32 (4) pp. 676-682.

Skarli, M; Yang, SY; Bouloux, P; Yellon, DM; Goldspink, G; (1998) Up-regulation and alternative splicing of the IGF-1 gene in the rabbit heart following a brief pressure/volume overload. J PHYSIOL-LONDON , 509P 192P - 193P.

Sporton, SCE; Taggart, P; Walker, JM; James, PR; Hardman, SMC; (1998) Local QT interval changes during coronary angioplasty. Heart , 79 (SUPPL. 1)

Stafford, M; Wells, JCK; Fewtrell, M; (1998) Relationship of physical activity and TV watching with body weight and fatness. Letter. JAMA , 4998 (280) pp. 1230-1231.

Stanton, AV; Chapman, JN; Sever, PS; Poulter, NR; Hughes, AD; Thom, SA; (1998) Greater regression of early atherosclerosis by calcium channel blockade than by angiotensin converting enzyme inhibition. JOURNAL OF HYPERTENSION , 16 S25-S25.

Stoschitzky, K; (1998) Angiotensin II, VEGF, and diabetic retinopathy. Lancet , 351 (9105) pp. 836-837. 10.1016/S0140-6736(05)78972-8.

Sumeray, MS; Rees, DD; Yellon, DM; (1998) Endothelial nitric oxide synthase protects murine myocardium against global ischaemia-reperfusion injury. In: (pp. P27-).

Sumeray, MS; Yellon, DM; (1998) Characterisation and validation of a murine model of global ischaemia-reperfusion injury. MOL CELL BIOCHEM , 186 (1-2) 61 - 68.

Sumeray, MS; Yellon, DM; (1998) Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium. BASIC RES CARDIOL , 93 (5) 384 - 390.

Sumeray, MS; Yellon, DM; (1998) Ischaemic preconditioning. In: Grace, PA and Mathie, RT, (eds.) Ischaemic-reperfusion injury. (pp. 328-343). Blackwell Science

Sutton, PMI; Taggart, P; Trimlett, R; Pugsley, W; Kallis, P; (1998) Ischemic epicardial activation delay: An antiarrhythmic or proarrhythmic mechanism? In: (pp. p. 847).

Sutton, PMI; Taggart, P; Trimlett, R; Pugsley, W; Kallis, P; (1998) Ischemic epicardial activation delay: An antiarrhythmic or proarrhythmic mechanism? CIRCULATION , 98 (17) p. 164.

T

Taggart, P; Sutton, PMI; Opthof, T; Coronel, R; Trimlett, R; Pugsley, W; Kallis, P; (1998) Early onset of stepwise transmural activation delay in patients with coronary heart disease during ischemia. CIRCULATION , 98 (17) p. 817.

Taggart, P; Sutton, PMI; Opthof, T; Coronel, R; Trimlett, R; Pugsley, W; Kallis, P; (1998) Early onset of stepwise transmural activation delay in patients with coronary heart disease during ischemia time course and dissociation of action potential duration and refractoriness during early ischemia in patients with coronary heart disease. In: (pp. I 817-).

Talmud, PJ; Bujac, SR; Hall, S; Humphries, SE; Miller, GJ; (1998) LPL gene: Smoking interaction in the determination of ischaemic heart disease risk. ATHEROSCLEROSIS , 141 (1) 182 - 182.

Talmud, PJ; Palmen, J; Walker, M; (1998) Identification of genetic variation in the human hormone-sensitive lipase gene and 5 ' sequences: Homology of 5 ' sequences with mouse promoter and identification of potential regulatory elements. BIOCHEM BIOPH RES CO , 252 (3) 661 - 668.

Talmud, PJ; Palmen, J; Walker, M; (1998) Identification of genetic variation in the human hormone-sensitive lipase gene and 5' sequences: homology of 5' sequences with mouse promoter and identification of potential regulatory elements. BIOCHEM BIOPHYS RES COMMUN , 252 (3) pp. 661-668.

Taylor, AM; Mohiaddin, RH; (1998) Quantification of coronary flow by magnetic resonance imaging. The International Journal of Cardiac Imaging , 14 pp. 187-189.

Thom, SA; Gao, X; Stanton, AV; Chapman, JN; Bharath, A; Hughes, AD; (1998) A computer system for automated retinal microvascular architecture quantification. JOURNAL OF HYPERTENSION , 16 S106-S106.

Traeger, S; Mavroidis, N; Kanavakis, E; Drogari, E; Humphries, SE; Day, IN; Kattamis, C; (1998) Analysis of low density lipoprotein receptor gene mutations and microsatellite haplotypes in Greek FH heterozygous children: six independent ancestors account for 60% of probands. HUM GENET , 102 (3) pp. 343-347.

U

Unlu, S; Mason, CD; Hughes, AD; (1998) Platelet-derived growth factor-BB induces apoptosis in cultured vascular smooth muscle cells derived from human saphenous vein. Biochem Soc Trans , 26 (4) S325-.

Unlu, S; Mason, CD; Hughes, AD; (1998) Role of isoprenylation in the inhibitory action of lovastatin on proliferation of SV40 immortalized human saphenous vein smooth muscle cells. Biochem Soc Trans , 26 (4) S324-.

Unlu, S; Mason, CD; Schachter, M; Hughes, AD; (1998) Interactions between HMG-CoA reductase inhibition and UVB irradiation on proliferation and apoptosis in SM1 smooth muscle cells. Biochem Soc Trans , 26 (4) S322-.

V

Volans, GN; Lambiase, D; (1998) Intoxications relevant to surgical practice. In: Hanson, G, (ed.) Critical care of the Surgical Patient. A Companion to Bailey & Loves' Short Practice of Surgery. Hodder Arnold

van Doorn, CA; Yates, R; Tsang, VT; (1998) Endocarditis as the first presentation of AIDS in infancy. Arch Dis Child , 79 (2) pp. 179-180.

W

Walker, AP; Wallace, DF; Partridge, J; Bomford, AB; Dooley, JS; (1998) Atypical haemochromatosis: Phenotypic spectrum and beta(2)-microglobulin candidate gene analysis. Presented at: UNSPECIFIED.

Wallace, DF; Partridge, J; Dooley, JS; Walker, AP; (1998) Classical phenotype of genetic haemochromatosis in a Cys282Tyr heterozygote due to compound heterozygosity with a novel splice site mutation. HEPATOLOGY , 28 (4) 526A - 526A.

Wallace, DF; Partridge, J; Robertson, A; Simpson, VMA; Worwood, M; Bomford, AB; Volz, A; ... Walker, AP; + view all (1998) A 6p22 reference map of leukocyte DNA: exclusion of rearrangement in four cases of atypical haemochromatosis. In: EUR J HUM GENET. (pp. 523 - 526). STOCKTON PRESS

Wang, X; Lewis, DA; Kim, HK; Tazelaar, HD; Park, YS; McGregor, CG; Miller, VM; (1998) Alterations in mRNA for inducible and endothelial nitric oxide synthase and plasma nitric oxide with rejection and/or infection of allotransplanted lungs. Transplantation , 66 (5) pp. 567-572.

Webster, GJM; Saeb-Parsy, K; Davies, SE; Bimpong, A; Wallace, DF; Whalley, S; Marley, R; ... Dusheiko, GM; + view all (1998) The effect of heterozygosity for C282Y mutation on fibrosis and liver iron status in chronic hepatitis C. Presented at: UNSPECIFIED.

Wiesmann, F; Gatehouse, PD; Panting, JR; Taylor, AM; Firmin, DN; Pennell, DJ; (1998) Comparison of fast spiral, echo planar and FLASH magnetic resonance imaging for cardiac volumetry at 0.5T. Journal of Magnetic Resonance Imaging , 8 pp. 1033-1039.

Wijetunge, S; Hughes, AD; (1998) Tyrosine phosphatases regulate voltage-operated calcium channels in smooth muscle cells isolated from rabbit ear artery. JOURNAL OF VASCULAR RESEARCH , 35 p. 12.

Williams, B; (1998) Mechanical influences on vascular smooth muscle cell function. In: (pp. pp. 1921-1929).

Wilson, DJ; Gahan, M; Haddad, L; Heath, K; Whittal, RA; Williams, RR; Humphries, SE; (1998) A World Wide Web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: Sequence-based, tabular, and direct submission data handling. AM J CARDIOL , 81 (12) 1509 - +.

Worwood, M; Bowen, DJ; Burnett, AK; Jackson, HA; Lawless, S; Raha-Chowdhury, R; Shearman, JD; ... Pointon, JJ; + view all (1998) H63D is an haemochromatosis associated allele - Reply. GUT , 43 (3) 441 - 442.

X

Xie, L; Clunn, GF; Lymn, JS; Hughes, AD; (1998) Role of intracellular calcium ([Ca2+](i)) and tyrosine phosphorylation in adhesion of cultured vascular smooth muscle cells to fibrinogen. CARDIOVASCULAR RESEARCH , 39 (2) pp. 475-484. 10.1016/S0008-6363(98)00079-0.

Y

Yamashita, N; Baxter, GF; Yellon, DM; (1998) Delayed myocardial protection following exercise appears to involve protein kinase C in rat heart. In: (pp. I 620-).

Yamashita, N; Baxter, GF; Yellon, DM; (1998) Delayed myocardial protection following exercise appears to involve protein kinase C pathway in rat heart. CIRCULATION , 98 (17) 620 - 620.

Ye, S; Humphries, S; Henney, A; (1998) Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis. CLIN SCI COLCH , 94 (2) pp. 103-110.

Yeatman, M; Daggett, CW; Parker, W; Byrne, GW; Logan, JS; Platt, JL; Davis, RD; (1998) Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation , 65 (8) pp. 1084-1093.

Yi, G; Elliott, P; McKenna, WJ; Prasad, K; Sharma, S; Guo, XH; Camm, AJ; (1998) QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. AMERICAN JOURNAL OF CARDIOLOGY , 82 (12) pp. 1514-1519. 10.1016/S0002-9149(98)00696-1.

Yi, G; Elliott, P; McKenna, WJ; Prasad, K; Sharma, S; Guo, XH; Camm, AJ; (1998) QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. The American Journal of Cardiology , 82 pp. 1514-1519.

Yi, G; Prasad, K; Elliott, P; Sharma, S; Guo, X; Mckenna, WJ; Malik, M; (1998) T wave complexity in patients with Hypertrophic Cardiomyopathy. In: (pp. pp. 2382-2386).

Yi, G; Prasad, K; Elliott, P; Sharma, S; Guo, XH; McKenna, WJ; Malik, M; (1998) T wave complexity in patients with hypertrophic cardiomyopathy. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , 21 (11) pp. 2382-2386. 10.1111/j.1540-8159.1998.tb01186.x.

This list was generated on Sun Apr 15 03:05:52 2018 BST.